Document is current
Any future updates will be listed below
-
Authors
Mamesaya, Nobuaki
Muramatsu, Koji
Yabe, Michitoshi
Kodama, Hiroaki
Nishioka, Naoya
Miyawaki, Taichi
Miyawaki, Eriko
Kobayashi, Haruki
Omori, Shota
Wakuda, Kazushige
Ono, Akira
Kenmotsu, Hirotsugu
Naito, Tateaki
Murakami, Haruyasu
Harada, Hideyuki
Sugino, Takashi
Shimizu, Tetsuo
Gon, Yasuhiro
Takahashi, Toshiaki
- License Information
-
More Information
Article History
Received: 14 August 2020
Accepted: 15 December 2020
First Online: 7 January 2021
Compliance with ethical standards
:
: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. NM reports grants and personal fees from Boehringer Ingelheim, personal fees from Boehringer Ingelheim, AstraZeneca KK, MSD Co., Ltd., Chugai Pharmaceutical Co.. HK reports personal fees from Eli Lilly K.K, and Taiho Pharmaceutical Co., Ltd.. SO reports personal fees from Chugai Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd., MSD Co., Ltd., and Daiichi Sankyo Co., Ltd.. KW reports grants and personal fees from AstraZeneca KK, Chugai Pharmaceutical Co., Ltd., personal fees from Taiho Pharmaceutical, Boehringer Ingelheim, Eli Lilly K.K., Ono Pharmaceutical, and MSD Co., Ltd., grants from Novartis, and Abbvie. AO reports grants from Taiho Pharmaceutical, Ono Pharmaceutical, Chugai Pharmaceutical Co., Ltd., and Novartis Pharma K.K.. HK reports grants and personal fees from AstraZeneca KK, Pfizer Japan, Inc., Novartis Pharma K.K., and Chugai Pharmaceutical Co., Ltd., personal fees from Boehringer Ingelheim, Kyowa Hakko Kirin Co., Ltd., Pfizer K.K., Eli Lilly K.K, Bristol-Myers Squibb, Ono Pharmaceutical Co, Ltd., and MSD K.K., grants from Daiichi-Sankyo Co., Ltd.. TN reports grants from Ono Pharmaceutical Co., Ltd., Pfizer US, Inc., and Mochida Pharmaceutical Co. Ltd.. HM reports grants and personal fees from AstraZeneca KK, Eli Lilly Japan K.K., Chugai Pharmaceutical Co., Ltd., Taiho Pharmaceutical, Daiichi Sankyo, Novartis, and Takeda., grants from Abbvie, IQvia, personal fees from Pfizer Japan, Inc., Bristol-Myers Squibb Japan, and Ono Pharmaceutical. HH reports personal fees from Eli Lilly Japan K.K, Daiichi sankyo pharmaceutical Co., Astrazeneka pharmaceutical co., Brain labo co., and Chugai Pharmaceutical Co., grants from Japan Agency for Medical Research and Development, and The National Cancer Center Research and Development fund. TT reports grants and personal fees from AstraZeneca KK, Pfizer Japan, Inc., Eli Lilly Japan K.K., Chugai Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., MSD K.K., Boehringer Ingelheim Japan, Inc., and Pfizer Japan, Inc., personal fees from Roche Diagnostics K.K.. All the remaining authors declare no conflicts of interest.
